Drug Shortage Report for SANDOZ SILODOSIN

Last updated on 2021-11-24 History
Report ID 148767
Drug Identification Number 02475421
Brand name SANDOZ SILODOSIN
Common or Proper name SILODOSIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) SILODOSIN
Strength(s) 4MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 30HGC BO
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-11-03
Estimated end date 2021-11-26
Actual end date 2021-11-24
Shortage status Resolved
Updated date 2021-11-24
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-11-24 French Compare
v7 2021-11-24 English Compare
v6 2021-11-15 French Compare
v5 2021-11-15 English Compare
v4 2021-11-08 French Compare
v3 2021-11-08 English Compare
v2 2021-11-03 French Compare
v1 2021-11-03 English Compare